Crossref
journal-article
Elsevier BV
Biochemical and Biophysical Research Communications (78)
References
18
Referenced
150
10.1093/hmg/9.19.2811
/ Hum. Mol. Genet. / Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila by Chan (2000)10.1038/502
/ Nat. Genet. / Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 by Cummings (1998)10.1126/science.1067389
/ Science / Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease by Auluck (2002)10.1097/00005072-199804000-00005
/ J. Neuropathol. Exp. Neurol. / Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson’s disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity by Irizarry (1998)10.1038/42166
/ Nature / Alpha-synuclein in Lewy bodies by Spillantini (1997)10.1074/jbc.M400255200
/ J. Biol. Chem. / Hsp70 reduces alpha-synuclein aggregation and toxicity by Klucken (2004)10.1046/j.1471-4159.2002.01190.x
/ J. Neurochem. / TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation by McLean (2002)10.1093/hmg/10.12.1307
/ Human. Mol. Genet. / Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington’s disease by Sittler (2001)10.1038/nm1102-1185
/ Nat. Med. / Pharmacological prevention of parkinson disease in Drosophila by Auluck (2002)10.1093/hmg/ddh083
/ Hum. Mol. Genet. / CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation by Petrucelli (2004)10.1016/S0306-4522(01)00113-0
/ Neuroscience / α-Synuclein-enhanced green fluorescent protein fusion proteins form proteasomal sensitive inclusions in primary neurons by McLean (2001)10.1074/jbc.275.12.8812
/ J. Biol. Chem. / Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson’s disease-linked mutations by McLean (2000)10.1038/8820
/ Nat. Genet. / Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions by Engelender (1999)10.1046/j.1471-4159.2001.00301.x
/ J. Neurochem. / Interaction of α-synuclein and synphilin-1: effect of Parkinson’s disease associated mutations by Kawamata (2001)10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.0.CO;2-B
/ Ann. Neurol. / Synphilin-1 is present in Lewy bodies in Parkinson’s disease by Wakabayashi (2000)10.1007/BF00687787
/ Acta. Neuropathol. (Berl.) / Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study by Kuzuhara (1988)10.1021/bi030086j
/ Biochemistry / Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson’s disease by Volles (2003)10.1146/annurev.neuro.26.010302.081142
/ Annu. Rev. Neurosci. / Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders by Caughey (2003)
Dates
Type | When |
---|---|
Created | 21 years, 1 month ago (July 22, 2004, 7:34 a.m.) |
Deposited | 6 years, 6 months ago (Feb. 7, 2019, 9:03 p.m.) |
Indexed | 9 months, 2 weeks ago (Nov. 19, 2024, 10:51 a.m.) |
Issued | 21 years, 1 month ago (Aug. 1, 2004) |
Published | 21 years, 1 month ago (Aug. 1, 2004) |
Published Print | 21 years, 1 month ago (Aug. 1, 2004) |
@article{McLean_2004, title={Geldanamycin induces Hsp70 and prevents α-synuclein aggregation and toxicity in vitro}, volume={321}, ISSN={0006-291X}, url={http://dx.doi.org/10.1016/j.bbrc.2004.07.021}, DOI={10.1016/j.bbrc.2004.07.021}, number={3}, journal={Biochemical and Biophysical Research Communications}, publisher={Elsevier BV}, author={McLean, Pamela J. and Klucken, Jochen and Shin, Youngah and Hyman, Bradley T.}, year={2004}, month=aug, pages={665–669} }